The body's own surveillance system against cancer
Together with fellow researchers from other institutions the HZI scientists discovered that the state of senescence of the cells allows detection by the immune system. This results in an intensified surveillance by the bodys own defense system. The researchers propose that a mechanism, similar to the one shown for the liver, may play a key role in other organs as well. The results of this project have now been published in an online release by the scientific journal Nature.
At the end of their life cycle or if their genetic information has been damaged or modified, cells either pass through a precisely organized programme of cell death or decline into a kind of hibernation, the so-called senescence. This resting state prevents defective cells from proliferating in an uncontrolled way and thus avoids the formation of tumors. Professor Lars Zender, head of the HZI research group Chronic Infections and Cancer, and his team were able to demonstrate that the immune system plays a crucial role in the continuous surveillance of these resting cells. By this means the body avoids further alterations of cells that possibly result in cancer, explains Lars Zender.
For the investigation of the association between senescence, immune defense and cancer development, Lars Zender and his team used molecular biological methods in order to induce the senescence programme in liver cells of laboratory mice. We were distinctly able to see that the immune system initiates a reaction against the modified cells, says Zender. After a few weeks the modified cells were eliminated.
In immunodeficient mice that lack protective T-helper cells, researchers were able to observe that senescent liver cells progressed to develop liver cell carcinoma. This clearly shows how important the surveillance of senescent cells is a task carried out by the immune system, and specifically, by the T-helper cells, says Zender.
This newly identified mechanism may also explain the fact that HIV-positive patients have an increased risk of developing liver cancer. To investigate this phenomenon, researchers determined the number of senescent cells in the liver of Hepatitis C patients that were also HIV-positive. The results were compared to the numbers of a Hepatitis C patient group without HIV infection. As expected, in the former group the number of senescent cells was strongly increased, says Zender. In HIV patients, the T-helper cell-mediated immune defense is impaired. As a consequence, in livers of HIV patients, senescent liver cells probably cannot be eliminated effectively.
The authors of this study are hopeful that the newly discovered mechanism enables the design of prospective new prevention and therapy strategies for cancer diseases.
Nature, Advanced Online Publication, DOI: 10.1038/nature10599